Literature DB >> 10369312

Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease.

V Haroutunian1, D P Purohit, D P Perl, D Marin, K Khan, M Lantz, K L Davis, R C Mohs.   

Abstract

BACKGROUND: The relationship between neuropathological lesions and mild, "preclinical," cognitive impairments of Alzheimer disease is poorly understood. Identification of the lesions that are most closely associated with the earliest symptoms of Alzheimer disease is crucial to the understanding of the disease process and the development of treatment strategies to affect its progression. DESIGN AND MAIN OUTCOME MEASURES: We examined the extent of neurofibrillary tangles (NFTs) in 4 neocortical regions, the hippocampus, the entorhinal cortex, and the amygdala in 65 elderly subjects with no dementia, questionable dementia, mild dementia, or moderate dementia as assessed using the Clinical Dementia Rating Scale (CDR). SETTING AND PATIENTS: Postmortem study of nursing home residents.
RESULTS: Neurofibrillary tangles were present in the entorhinal cortex and the hippocampus of all subjects, including those without cognitive deficits. Neocortical NFTs were mostly absent in the nondemented (CDR score, 0.0) subjects. The density of NFTs in the questionably demented (CDR score, 0.5) subjects was not significantly increased (P>.20) relative to the nondemented group in any of the brain regions studied. Significant increases (P<.04) in NFT density become apparent first in the amygdala and the temporal cortex in subjects rated to be mildly impaired (CDR score, 1.0). By the time that cognitive impairments were judged to be moderately severe (CDR score, 2.0), all regions of the brain examined, except for the occipital cortex, were significantly (P<.05) involved.
CONCLUSIONS: Some NFTs are present in the entorhinal cortex and hippocampus of most elderly individuals irrespective of their cognitive status, but the density of NFTs increases as a function of dementia severity.

Entities:  

Mesh:

Year:  1999        PMID: 10369312     DOI: 10.1001/archneur.56.6.713

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  85 in total

1.  Entorhinal verrucae geometry is coincident and correlates with Alzheimer's lesions: a combined neuropathology and high-resolution ex vivo MRI analysis.

Authors:  Jean C Augustinack; Kristen E Huber; Gheorghe M Postelnicu; Sita Kakunoori; Ruopeng Wang; André J W van der Kouwe; Lawrence L Wald; Thor D Stein; Matthew P Frosch; Bruce Fischl
Journal:  Acta Neuropathol       Date:  2011-12-13       Impact factor: 17.088

2.  Differential age-related decline in conflict-driven task-set shielding from emotional versus non-emotional distracters.

Authors:  Jim M Monti; Sandra Weintraub; Tobias Egner
Journal:  Neuropsychologia       Date:  2010-02-20       Impact factor: 3.139

3.  Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology.

Authors:  Michal Schnaider Beeri; Jeremy M Silverman; Kenneth L Davis; Deborah Marin; Hillel Z Grossman; James Schmeidler; Dushyant P Purohit; Daniel P Perl; Michael Davidson; Richard C Mohs; Vahram Haroutunian
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-04       Impact factor: 6.053

4.  Accelerated clinical decline in well-educated patients with frontotemporal lobar degenerations.

Authors:  Robert Perneczky; Corina Pohl; Susanne Bornschein; Hans Förstl; Alexander Kurz; Janine Diehl-Schmid
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-03-03       Impact factor: 5.270

5.  Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

Authors:  Joseph L Price; Daniel W McKeel; Virginia D Buckles; Catherine M Roe; Chengjie Xiong; Michael Grundman; Lawrence A Hansen; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Charles D Smith; Daron G Davis; Frederick A Schmitt; William R Markesbery; Jeffrey Kaye; Roger Kurlan; Christine Hulette; Brenda F Kurland; Roger Higdon; Walter Kukull; John C Morris
Journal:  Neurobiol Aging       Date:  2009-04-18       Impact factor: 4.673

Review 6.  Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

Authors:  J C Morris; J L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

7.  Short latency afferent inhibition differs among the subtypes of mild cognitive impairment.

Authors:  Raffaele Nardone; Jürgen Bergmann; Monica Christova; Francesca Caleri; Frediano Tezzon; Gunther Ladurner; Eugen Trinka; Stefan Golaszewski
Journal:  J Neural Transm (Vienna)       Date:  2011-10-21       Impact factor: 3.575

8.  Clinical dementia rating performed several years prior to death predicts regional Alzheimer's neuropathology.

Authors:  Michal Schnaider Beeri; Jeremy M Silverman; James Schmeidler; Michael Wysocki; Hillel Z Grossman; Dushyant P Purohit; Daniel P Perl; Vahram Haroutunian
Journal:  Dement Geriatr Cogn Disord       Date:  2008-03-27       Impact factor: 2.959

9.  The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia.

Authors:  Panos Roussos; Pavel Katsel; Peter Fam; Weilun Tan; Dushyant P Purohit; Vahram Haroutunian
Journal:  Alzheimers Dement       Date:  2014-12-09       Impact factor: 21.566

10.  Decreased level of olfactory receptors in blood cells following traumatic brain injury and potential association with tauopathy.

Authors:  Wei Zhao; Lap Ho; Merina Varghese; Shrishailam Yemul; Kristen Dams-O'Connor; Wayne Gordon; Lindsay Knable; Daniel Freire; Vahram Haroutunian; Giulio Maria Pasinetti
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.